As of April 1, 2026, Tonix Pharmaceuticals Holding Corp. (TNXP) trades at $13.68, marking a 0.51% decline in the latest trading session. This analysis explores key technical levels, recent market context for the biopharmaceutical stock, and potential near-term price scenarios based on current trading patterns. No recent earnings data is available for TNXP as of this writing, so price action is currently driven primarily by sector sentiment and technical flows rather than quarterly fundamental pe
TNXP Stock Analysis: Tonix Pharmaceuticals Holding Corp dips 0.51 pct to 13.68
TNXP - Stock Analysis
4063 Comments
1844 Likes
1
Rocelin
Daily Reader
2 hours ago
Someone hand you a crown already. 👑
👍 72
Reply
2
Alleson
Influential Reader
5 hours ago
Active sectors are attracting more attention, driving rotation and selective gains.
👍 162
Reply
3
Kalsoom
Elite Member
1 day ago
Free US stock correlation to major indices and sector benchmarks for performance attribution analysis and return source identification. We help you understand how your portfolio moves relative to broader market benchmarks and identify return drivers. We provide correlation analysis, attribution breakdown, and benchmark comparison for comprehensive coverage. Understand performance drivers with our comprehensive correlation and attribution analysis tools for portfolio optimization.
👍 33
Reply
4
Shyleigh
Returning User
1 day ago
How are you not famous yet? 🌟
👍 146
Reply
5
Katyna
New Visitor
2 days ago
That was basically magic in action.
👍 25
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.